Clinical Trial Update: Erlotinib and Chemotherapy for 2nd Line Treatment (Tx) of Metastatic Colorectal Cancer (mCRC) [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating erlotinib in combination with chemotherapy as second-line treatment for metastatic colorectal cancer was terminated, with re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• ERLOTINIB (Erlotinib)

Snippet

Sponsor: OHSU Knight Cancer Institute | Conditions: Metastatic Colorectal Cancer | Phase 2 | Status: TERMINATED | Results posted: 2014-09-26